Azenta Inc (AZTA)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $1.91B
Last updated: Nov 17, 2026 at 11:04 AM ET
Azenta Inc (AZTA) Financials: Revenue, Profit and Cash Flow
Azenta reported revenue of $593.82M for the fiscal year ended Sep 30, 2025, up 3.6% from the year before. That year, net income was -$55.76M with a net margin of -9.4%, operating cash flow was $72.18M and free cash flow was $38.32M. The quarter ended Jun 30, 2026 had revenue of $161.18M and net income of $2.46M.
Revenue and Margins
The operating margin was -4.5% in the fiscal year ended Sep 2025. Over the 9 years to Sep 2025, revenue grew from $434.01M, a compound annual rate of 3.5%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Sep 2025 | $593.82M | +3.6% | 45.5% | -4.5% | -9.4% |
| Sep 2024 | $573.45M | +4.0% | 44.4% | -8.9% | -28.8% |
| Sep 2023 | $551.49M | -0.7% | 43.4% | -11.1% | -2.7% |
| Sep 2022 | $555.50M | +8.1% | 46.0% | -4.5% | 384.0% |
| Sep 2021 | $513.70M | +32.2% | 47.5% | -6.1% | 21.6% |
| Sep 2020 | $388.54M | +16.3% | 44.3% | -9.4% | 16.7% |
| Sep 2019 | $334.18M | -47.1% | 40.3% | -14.2% | 130.9% |
| Sep 2018 | $631.56M | +19.7% | 39.0% | 5.0% | 18.4% |
| Sep 2017 | $527.50M | +21.5% | 37.7% | 2.7% | 11.9% |
| Sep 2016 | $434.01M | N/A | 36.1% | -3.9% | -16.0% |
Income Statement
In the fiscal year ended Sep 2025, the net loss narrowed from the year before. In the quarter ended Jun 2026, net income turned positive after a loss in the same quarter a year earlier.
Annual
| Line item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $593.82M | $573.45M | $551.49M | $555.50M | $513.70M | $388.54M | $334.18M | $631.56M | $527.50M | $434.01M |
| Cost of revenue | $323.54M | $318.83M | $312.28M | $299.91M | $269.89M | $216.39M | $199.57M | $385.48M | $328.61M | $277.32M |
| Gross profit | $270.28M | $254.62M | $239.21M | $255.58M | $243.81M | $172.15M | $134.60M | $246.08M | $198.89M | $156.69M |
| Research and development | $30.39M | $31.52M | $32.14M | $27.54M | $22.41M | $17.82M | $17.32M | $46.94M | $39.88M | $44.24M |
| Operating income | -$26.84M | -$51.28M | -$61.25M | -$24.73M | -$31.09M | -$36.60M | -$47.43M | $31.41M | $14.32M | -$17.05M |
| Net income | -$55.76M | -$164.90M | -$14.64M | $2.13B | $110.75M | $64.85M | $437.42M | $116.46M | $62.61M | -$69.48M |
| EBITDA | $33.71M | $32.70M | $14.17M | $26.18M | $17.99M | $27.53M | $6.76M | $66.24M | $41.02M | $9.95M |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $161.18M | $144.79M | $148.64M | $158.95M | $143.85M | $143.34M | $147.44M | $151.08M | $144.29M | $136.35M | $141.72M | $58.77M |
| Gross profit | $72.36M | $62.03M | $63.71M | $67.96M | $66.40M | $62.78M | $68.82M | $66.74M | $65.48M | $60.66M | $61.74M | $44.10M |
| Operating income | -$4.18M | -$165.79M | -$7.24M | $1.37M | -$1.85M | -$18.19M | -$8.70M | -$3.72M | -$7.11M | -$24.21M | -$16.25M | -$4.75M |
| Net income | $2.46M | -$160.80M | -$15.43M | $50.84M | -$47.99M | -$47.66M | -$10.99M | -$5.71M | -$6.58M | -$136.88M | -$15.72M | $3.00M |
Balance Sheet
As of Sep 2025, cash and equivalents exceeded short-term debt of $7.78M by $272.00M.
Annual
| Line item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $2.06B | $2.10B | $2.89B | $3.72B | $1.82B | $1.56B | $1.52B | $1.10B | $766.63M | $685.90M |
| Current assets | $708.34M | $833.03M | $1.42B | $2.46B | $777.37M | $649.45M | $647.14M | $564.06M | $351.78M | $299.33M |
| Cash and equivalents | $279.78M | $280.03M | $678.91M | $658.27M | $227.43M | $250.65M | $301.64M | $197.71M | $101.62M | $85.09M |
| Total liabilities | $332.60M | $332.42M | $351.22M | $352.74M | $494.18M | $345.65M | $377.05M | $377.43M | $158.98M | $132.22M |
| Short-term debt | $7.78M | $10.55M | $10.18M | $7.02M | $148.06M | $827.00K | $829.00K | $2.00M | $11.42M | $7.55M |
| Long-term debt | N/A | N/A | N/A | N/A | $49.68M | $49.59M | $50.31M | $194.07M | N/A | N/A |
| Shareholder equity | $1.73B | $1.77B | $2.53B | $3.36B | $1.33B | $1.21B | $1.14B | $717.83M | $607.64M | $553.69M |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $1.88B | $1.90B | $2.07B | $2.06B | $2.02B | $2.04B | $2.04B | $2.10B | $2.32B | $2.56B | $2.82B | $2.89B |
| Total liabilities | $366.08M | $349.21M | $359.60M | $333.61M | $345.50M | $340.43M | $322.24M | $331.07M | $332.90M | $340.63M | $380.65M | $351.22M |
| Cash and equivalents | $189.65M | $234.03M | $336.63M | $282.14M | $270.04M | $253.64M | $377.49M | $310.93M | $336.54M | $353.49M | $702.92M | $678.91M |
| Shareholder equity | $1.51B | $1.55B | $1.71B | $1.72B | $1.67B | $1.70B | $1.72B | $1.77B | $1.99B | $2.22B | $2.44B | $2.53B |
Cash Flow
In the fiscal year ended Sep 2025, free cash flow was 53.1% of operating cash flow.
Annual
| Line item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $72.18M | $49.74M | $5.83M | -$466.05M | $149.86M | $37.87M | $90.90M | $73.96M | $96.22M | $39.55M |
| Capital expenditures | $33.86M | $37.39M | $39.44M | $73.44M | $52.80M | $39.92M | $23.86M | $12.79M | $12.68M | $12.85M |
| Free cash flow | $38.32M | $12.35M | -$33.60M | -$539.48M | $97.05M | -$2.06M | $67.04M | $61.18M | $83.55M | $26.70M |
| Dividends paid | N/A | $0 | $0 | $7.49M | $29.73M | $29.51M | $28.89M | $28.29M | $27.93M | $27.50M |
| Share repurchases | $0 | $661.70M | $838.51M | $0 | $0 | N/A | N/A | N/A | N/A | N/A |
| Investing cash flow | -$90.46M | $224.74M | $431.38M | $1.47B | -$146.35M | -$22.74M | $211.31M | -$148.47M | -$54.19M | -$10.87M |
| Financing cash flow | -$9.59M | -$659.21M | -$840.46M | -$62.76M | -$25.91M | -$27.02M | -$191.16M | $170.28M | -$25.92M | -$25.96M |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.45M | $13.51M | $20.85M | $2.17M | $25.81M | $14.40M | $29.80M | $17.59M | $9.78M | $8.62M | $13.76M | $28.26M |
| Capital expenditures | $6.64M | $7.40M | $6.19M | $7.86M | $10.84M | $7.41M | $7.75M | $9.38M | $8.47M | $8.25M | $11.29M | $10.22M |
| Free cash flow | -$5.19M | $6.11M | $14.65M | -$5.69M | $14.97M | $7.00M | $22.05M | $8.21M | $1.31M | $364.00K | $2.46M | $18.04M |
Frequently Asked Questions About AZTA
What is Azenta's annual revenue?
Azenta reported revenue of $593.82M for the fiscal year ended Sep 30, 2025.
How fast is Azenta's revenue growing?
Revenue was up 3.6% for the fiscal year ended Sep 30, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 2.2%.
Is Azenta profitable?
No. Azenta reported net income of -$55.76M for the fiscal year ended Sep 30, 2025, with a net margin of -9.4%.
How much free cash flow does AZTA generate?
For the fiscal year ended Sep 30, 2025, operating cash flow of $72.18M minus capital expenditures of $33.86M produced free cash flow of $38.32M.
How much debt does Azenta have?
The balance sheet dated Sep 30, 2025 reported short-term debt of $7.78M and cash and equivalents of $279.78M.
AZTA pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts